IN2015DN03947A - - Google Patents

Info

Publication number
IN2015DN03947A
IN2015DN03947A IN3947DEN2015A IN2015DN03947A IN 2015DN03947 A IN2015DN03947 A IN 2015DN03947A IN 3947DEN2015 A IN3947DEN2015 A IN 3947DEN2015A IN 2015DN03947 A IN2015DN03947 A IN 2015DN03947A
Authority
IN
India
Prior art keywords
argatroban
amino
methyl
sterile
aqueous
Prior art date
Application number
Other languages
English (en)
Inventor
Owoo George
A Burgos Richard
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of IN2015DN03947A publication Critical patent/IN2015DN03947A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3947DEN2015 2005-09-01 2006-08-28 IN2015DN03947A (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71340305P 2005-09-01 2005-09-01
PCT/US2006/033432 WO2007027565A2 (en) 2005-09-01 2006-08-28 Argatroban formulation comprising an acid as solubilizer

Publications (1)

Publication Number Publication Date
IN2015DN03947A true IN2015DN03947A (pl) 2015-10-02

Family

ID=37809398

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3947DEN2015 IN2015DN03947A (pl) 2005-09-01 2006-08-28

Country Status (23)

Country Link
US (3) US7642271B2 (pl)
EP (1) EP1948133B1 (pl)
JP (1) JP5189980B2 (pl)
KR (3) KR101753949B1 (pl)
CN (2) CN102895179B (pl)
AT (1) ATE514416T1 (pl)
AU (1) AU2006285097B2 (pl)
BR (1) BRPI0616127B8 (pl)
CA (1) CA2617920C (pl)
CY (1) CY1112109T1 (pl)
DK (1) DK1948133T3 (pl)
ES (1) ES2368758T3 (pl)
HK (2) HK1123193A1 (pl)
IL (2) IL189290A (pl)
IN (1) IN2015DN03947A (pl)
MX (1) MX2008002177A (pl)
NZ (1) NZ565821A (pl)
PL (1) PL1948133T3 (pl)
PT (1) PT1948133E (pl)
RU (1) RU2416393C2 (pl)
SI (1) SI1948133T1 (pl)
WO (1) WO2007027565A2 (pl)
ZA (1) ZA200802667B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5189980B2 (ja) * 2005-09-01 2013-04-24 バクスター・インターナショナル・インコーポレイテッド 可溶化剤として酸を含むアルガトロバン処方物
CA2669727C (en) * 2006-09-27 2014-10-28 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US7687516B2 (en) * 2006-09-27 2010-03-30 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US20100076019A1 (en) * 2006-10-11 2010-03-25 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
US20090221637A1 (en) * 2008-02-29 2009-09-03 Baxter International Inc. Solid-state salt argatroban formulations and methods for producing and using the same
US7915290B2 (en) * 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
CN101598725B (zh) * 2009-06-23 2012-07-18 南通大学附属医院 阿加曲班在血细胞和生化常规分析中的应用
CN103167800A (zh) 2010-10-21 2013-06-19 Rtu制药有限责任公司 即用型酮咯酸注射液
CN102120026A (zh) * 2011-03-03 2011-07-13 天津市炜杰科技有限公司 以醇作为增溶剂的21(s)阿加曲班静脉注射液
CN102119922A (zh) * 2011-03-03 2011-07-13 天津市炜杰科技有限公司 以酸作为增溶剂的21(s)阿加曲班静脉注射液
CN102228677A (zh) * 2011-06-17 2011-11-02 天津市炜杰科技有限公司 以酸作为增溶剂的21(r)阿加曲班静脉注射液
AR088372A1 (es) * 2011-10-19 2014-05-28 Otsuka Pharma Co Ltd Solucion para administracion oral
US10537535B2 (en) * 2015-12-04 2020-01-21 The Regents Of The University Of California Histone deacetylase inhibitors
CN107773533A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种新型凝血酶抑制剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE420919B (sv) * 1973-08-13 1981-11-09 Mitsubishi Chem Ind Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
US5214052A (en) * 1987-07-28 1993-05-25 Mitsubishi Kasei Corporation Method for dissolving arginineamides and pharmaceutical compositions containing them
CA2091715A1 (en) 1992-03-18 1993-09-19 Mitsubishi Kasei Corporation Argatroban preparations for ophthalmic use
US5506241A (en) * 1992-03-18 1996-04-09 Mitsubishi Chemical Corporation Argatroban preparations for ophthalmic use
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
JPH06219948A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法
EP0621036B1 (en) 1993-04-22 1999-03-17 Senju Pharmaceutical Co., Ltd. Aqueous compositions comprising argatroban and cyclodextrin or caffeine
JPH07228532A (ja) * 1993-04-22 1995-08-29 Senju Pharmaceut Co Ltd 水性液剤、その有効成分の溶解性向上方法および安定化方法
US5849843A (en) * 1993-11-16 1998-12-15 Baxter International Inc. Polymeric compositions for medical packaging and devices
US5998019A (en) * 1993-11-16 1999-12-07 Baxter International Inc. Multi-layered polymer structure for medical products
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
JPH10316569A (ja) * 1997-05-19 1998-12-02 Mitsubishi Chem Corp アルガトロバンの可溶化方法及びそれによるアルガトロバン含有外用水性薬剤
CN100344624C (zh) * 2003-03-20 2007-10-24 三菱制药株式会社 含有精氨酰胺类的医药制剂
JP2007523876A (ja) 2003-07-17 2007-08-23 スミスクライン・ビーチャム・コーポレイション Ｈｉｔ患者をアルガトロバンを用いて治療する方法
JP5189980B2 (ja) * 2005-09-01 2013-04-24 バクスター・インターナショナル・インコーポレイテッド 可溶化剤として酸を含むアルガトロバン処方物

Also Published As

Publication number Publication date
RU2008112311A (ru) 2009-10-10
BRPI0616127B1 (pt) 2020-05-12
RU2416393C2 (ru) 2011-04-20
AU2006285097A1 (en) 2007-03-08
EP1948133B1 (en) 2011-06-29
US20070049617A1 (en) 2007-03-01
ATE514416T1 (de) 2011-07-15
IL189290A (en) 2011-10-31
KR20140009599A (ko) 2014-01-22
CN101257890A (zh) 2008-09-03
WO2007027565A3 (en) 2007-10-04
CN102895179A (zh) 2013-01-30
BRPI0616127B8 (pt) 2021-05-25
NZ565821A (en) 2010-05-28
US7985757B2 (en) 2011-07-26
AU2006285097B2 (en) 2011-08-18
BRPI0616127A2 (pt) 2011-06-07
PL1948133T3 (pl) 2012-03-30
CA2617920C (en) 2014-05-27
CA2617920A1 (en) 2007-03-08
HK1178053A1 (en) 2013-09-06
US7642271B2 (en) 2010-01-05
IL208183A0 (en) 2010-12-30
CN101257890B (zh) 2012-10-31
JP2009507018A (ja) 2009-02-19
US8034830B2 (en) 2011-10-11
KR101753949B1 (ko) 2017-07-04
DK1948133T3 (da) 2011-10-03
KR20150108430A (ko) 2015-09-25
WO2007027565A2 (en) 2007-03-08
SI1948133T1 (sl) 2011-08-31
ZA200802667B (en) 2009-01-28
HK1123193A1 (en) 2009-06-12
ES2368758T3 (es) 2011-11-22
IL189290A0 (en) 2008-06-05
JP5189980B2 (ja) 2013-04-24
PT1948133E (pt) 2011-08-01
CY1112109T1 (el) 2015-11-04
US20100099705A1 (en) 2010-04-22
US20100099706A1 (en) 2010-04-22
KR20080042155A (ko) 2008-05-14
CN102895179B (zh) 2014-10-22
EP1948133A2 (en) 2008-07-30
MX2008002177A (es) 2008-04-22

Similar Documents

Publication Publication Date Title
IN2015DN03947A (pl)
EA200700389A1 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
NZ597260A (en) Formulations for parenteral delivery of compounds and uses thereof comprising methylnaltrexone
EA200970726A1 (ru) Твердый препарат, содержащий алоглиптин и пиоглитазон
HUP0303278A2 (hu) Fagyasztva szárított pantoprazol készítmény, eljárás az előállítására és pantoprazol injekció
WO2007005633A3 (en) Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
EA200500833A1 (ru) Получение стерильных водных суспензий, содержащих микронизированные кристаллические активные ингредиенты для ингаляции
JP2009507018A5 (pl)
RU2012113844A (ru) Пероральные суспензионные лекарственные формы ацетата эсликарбазепина
NZ228576A (en) Piroxicam as its alkali or alkaline earth metal salt
WO2003086324A3 (en) Preparation and use of a stable formulation of allosteric effector compounds
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
HUP0104161A2 (hu) Javított stabilitású, peptidalapú trombin inhibitort tartalmazó injekciós oldatok és eljárás az előállításukra
PL2094116T3 (pl) Stały lub wodny alkaliczny preparat obejmujący składnik kreatynowy, sposób jego wytwarzania i jego zastosowanie
CH647759A5 (it) Derivato della glicina, metodo per la sua preparazione e composizioni farmaceutiche che lo contengono.
GEP20125525B (en) Stable liquid pharmaceutical composition based on trazodone
EP1108429A3 (en) An improved amino acid composition for providing an amino acid supplement or protein substitute, particularly for the treatment and/or management of certain diseases
CN101732264B (zh) 一种头孢西酮钠冻干粉针剂
UA85066C2 (ru) Способ приготавлевания транс- или цис-диаммонийдихлородигидроксоплатины (iv) и ее применение при получении фармацевтически активных веществ
AU2003257473A1 (en) Modified amino acid for the inhibition of platelet aggregation
RU2011109921A (ru) Препараты канфосфамида и их получения
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
WO2003094889A1 (fr) Produit de lyophilisation
WO2006002887A8 (en) Aqueous drink solution of indibulin (d-24851) and an organic acid
WO2007062076A3 (en) Dexrazoxane formulations and methods